Insights on Clinical Trials

31. Optimizing Clinical Data: Reducing Redundancy For Efficiency 6/6/2025

    Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.

32. The Hidden Risk In Cell & Gene Therapy Commercialization 6/5/2025

    Of the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.

33. Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU 6/4/2025

    Discover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative. 

34. Supporting The Clinical Journey From Discovery To Delivery 6/3/2025

    Clinical Trials Day celebrates the science and collaboration driving medical breakthroughs — discover how Cryoport Systems helps power this progress behind the scenes.

     

35. Critical Imaging Risks In GLP-1 And Neurology Studies 5/27/2025

    As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that safeguards participant safety and supports robust, reproducible outcomes.

36. Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients 5/27/2025

    Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.

37. Bayesian Study Designs In Early-Phase Oncology Trials 5/23/2025

    In response to insufficient traditional dose-escalation methods, regulatory initiatives like the FDA’s Project Optimus advocate for identifying optimal biological doses rather than relying solely on maximum tolerated doses (MTD).

38. Optimizing Clinical Bridging Strategies For Combination Drug Products: A Risk-Based Approach 5/21/2025

    Clinical bridging studies demonstrate bioequivalence or bioavailability for drug-device combinations, using pharmacokinetic parameters and a risk-based, four-step approach to support regulatory approval and product transitions.

39. Top Biotech Hubs Around The World: Where Innovation Thrives In 2025 5/20/2025

    Explore the leading biotech hubs in 2025, what makes them unique, and how companies can leverage these ecosystems to accelerate innovation and growth.

40. Overview Of Obesity: Global Clinical Trials Landscape 5/20/2025

    This comprehensive overview of current and emerging obesity treatments provides insight into the growing global health crisis that is rising in prevalence across all demographics and income levels.